Edwards Lifesciences (EW) Other Operating Expenses (2017 - 2026)

Edwards Lifesciences' Other Operating Expenses history runs 5 years deep, the most recent figure standing at $14.2 million for Q1 2026.

• On a quarterly basis, Other Operating Expenses fell 25.65% year-over-year to $14.2 million in Q1 2026; TTM through Mar 2026 was $62.3 million, a 221.13% increase from a year earlier, with the FY2025 full-year figure at $67.2 million, up 22300.0% from the prior year.
• Other Operating Expenses retreated to $14.2 million in Q1 2026 per EW's latest filing, from $14.3 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $22.7 million in Q4 2024 and bottomed at -$22.4 million in Q3 2024.
• The 3-year median for Other Operating Expenses is $14.3 million (2025), against an average of $11.7 million.
• Biggest YoY gain for Other Operating Expenses was 155.8% in 2025; the steepest drop was 37.0% in 2025.
• Year by year, Other Operating Expenses stood at $22.7 million in 2024, then slumped by 37.0% to $14.3 million in 2025, then slipped by 0.7% to $14.2 million in 2026.
• Per Business Quant, the three latest EW Other Operating Expenses figures stand at $14.2 million (Q1 2026), $14.3 million (Q4 2025), and $12.5 million (Q3 2025).